1. Home
  2. GLND vs ONCY Comparison

GLND vs ONCY Comparison

Compare GLND & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GLND

Greenland Energy Company Common Stock

N/A

Current Price

$2.33

Market Cap

103.2M

Sector

Energy

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.86

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLND
ONCY
Founded
N/A
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Oil & Gas Production
Pharmaceuticals and Biotechnology
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
107.3M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
GLND
ONCY
Price
$2.33
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
1.0M
1.5M
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.77
52 Week High
$12.80
$1.51

Technical Indicators

Market Signals
Indicator
GLND
ONCY
Relative Strength Index (RSI) 43.64 45.25
Support Level N/A $0.81
Resistance Level $3.26 $1.06
Average True Range (ATR) 0.21 0.07
MACD 0.06 -0.00
Stochastic Oscillator 58.18 22.15

Price Performance

Historical Comparison
GLND
ONCY

About GLND Greenland Energy Company Common Stock

Greenland Energy Co is a Texas energy resources company focused on unlocking Greenland's vast hydrocarbon potential through the application of modern exploration technologies. It holds exclusive licenses to over 2-million acre area in the Jameson Land Basin, where its licenses cover the majority of the basin. The business model for the company is based on exploration and resource development in the frontier basins of Greenland. The company's primary focus is drilling the first wells on the project to conduct the necessary exploration, appraisal and evaluation.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: